Corporate Giving
Gilead Sciences funds nonprofit projects that address healthcare access and outcomes in HIV, liver disease, oncology, and chronic inflammatory diseases through data-driven, community-focused initiatives.
Funder: Gilead Sciences
Due Dates: Rolling
Funding Amounts: No stated upper limit; applicants should request the amount needed for project success.
Summary: Supports nonprofit-led projects addressing barriers to health care access, especially in HIV, liver disease, oncology, and chronic inflammatory diseases.
Key Information: Only tax-exempt nonprofits eligible; applications must be submitted at least six weeks before project start.
Description
Gilead Sciences' Corporate Giving program funds nonprofit organizations worldwide to address barriers to healthcare access and improve health outcomes. The program emphasizes collaborative, community-informed, and data-driven projects, with a focus on Gilead’s core therapeutic areas: HIV, liver diseases (including hepatitis B, C, D, and primary biliary cholangitis), oncology (hematology and solid tumors), and chronic inflammatory diseases. Grants support initiatives that expand care capacity, reduce disparities, strengthen healthcare infrastructure, and advocate for social change.
